- Report
- June 2025
- 150 Pages
Global
From €3431EUR$3,850USD£2,976GBP
- Report
- July 2025
- 478 Pages
Global
From €5213EUR$5,850USD£4,521GBP
- Report
- August 2024
- 135 Pages
Global
From €2672EUR$2,999USD£2,318GBP
- Report
- March 2025
- 224 Pages
Global
From €3965EUR$4,450USD£3,439GBP
- Training
- October 2025
- 1 Day
Global
€774EUR$900USD£649GBP
€894EUR$1,038USD£749GBP
- Training
- October 2025
- 3 Days
Asia Pacific
€1908EUR$2,216USD£1,599GBP
€2266EUR$2,632USD£1,899GBP
- Training
- October 2025
- 2 Days
Europe
€1550EUR$1,800USD£1,299GBP
€1789EUR$2,078USD£1,499GBP
- Report
- March 2024
- 78 Pages
Global
From €4411EUR$4,950USD£3,826GBP
- Report
- August 2022
- 30 Pages
Global
From €2896EUR$3,250USD£2,512GBP
- Report
- August 2022
- 110 Pages
Global
From €1782EUR$2,000USD£1,546GBP
- Report
- July 2022
- 71 Pages
Global
From €1782EUR$2,000USD£1,546GBP
- Report
- July 2022
- 57 Pages
Global
From €1782EUR$2,000USD£1,546GBP
- Report
- June 2022
- 93 Pages
Global
From €1782EUR$2,000USD£1,546GBP
- Training
- October 2021
- 1 Day
Latin America
From €1158EUR$1,299USD£1,004GBP
- Report
- February 2018
- 135 Pages
Global
From €4455EUR$5,000USD£3,864GBP
- Training
- 7 Hours
Global
- Training
- 4 Hours
Europe
- Training
- 90 Minutes
Europe
- Report
- December 2022
- 94 Pages
Global
From €1782EUR$2,000USD£1,546GBP
- Report
- October 2022
- 308 Pages
Global
From €2228EUR$2,500USD£1,932GBP

The Marketing Authorization market is a key component of the Drug Discovery process. It is the process of obtaining approval from regulatory authorities to market a drug or medical device. This process involves submitting a dossier of data to the relevant regulatory body, which is then reviewed to ensure the product meets safety and efficacy standards. The dossier includes pre-clinical and clinical data, manufacturing information, and other relevant information. The process also includes post-marketing surveillance to ensure the product continues to meet safety and efficacy standards.
Companies in the Marketing Authorization market include AbbVie, AstraZeneca, Bayer, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Sanofi. Show Less Read more